Merck & Co has offered a hefty $9.5 billion to take control of US biotech Cubist Pharmaceuticals, in another signal that big pharma's interest in antibiotics research is returning. Merck is offering ...
We’ve combed through everything announced for 2026 so far—from a rare MoMA retrospective to a Mr. Rodgers–inspired takeover of the Bronx Zoo and loads in between—and narrowed things down to these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback